Sarepta Therapeutics (NASDAQ:SRPT)After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy — DMD — to restore dystrophin […]
Submitted by Tim Price via The Cobden Centre,
“We’re not gonna make it, are we ? People, I mean.”
“It is in your nature to destroy yourselves.”
“Yeah. Major drag, huh ?”
From James Cameron’s ‘Terminator 2: Judgment Day’.
Here is a thought experiment. It is January 2000. The last wild Pyrenean ibex has been found dead, squashed by a tree. America Online has just […]
The main theme of the year so far has been the volatility in the tech stocks, with may high fliers dropping overnight, including the biotech darlings of the last few years. The money seems to be rotating into the materials. The possible reversal of the US Dollar strength along with firming in the price of energy has contributed. I have […]
Biotech Stocks to Watch in May 2015
Biotech Stocks to Watch in May 2015
By profitconfidentialMay 5, 2015 6:53:59 AM PDT| 19 View(s) | Rating PrintEmailThe best biotech stocks to watch for in May 2015 are businesses that dominate their respective market, command a diverse drug pipeline, and have lots of profits to show for it.Profitability is crucial given that the NASDAQ […]
S&P 500SPXA50R: % of stocks above 50 day moving average (red line)The blue vertical line shows Monday’s all time high in the index versus SPXA50RThe rotation out of the momentum stocks to defensive stocks was a non-event for the Dow:% of stocks above 200 DMANasdaq 100: Large Cap Tech and Biotech:
See the article here:
It Was a Bad Week To Stop […]
Share on StockTwitsEmbedThe world is awash in cash and time. It’s an interesting cocktail that has been brewing with the proliferation of money printing and smartphones. It makes sense to me that speculation would run rampant.My wife and I just made an offer on a home on Coronado. We were one of SIX. The counter came back at 10 percent […]
Related BIIBBiogen Continues To Decline After Friday’s RoutDid The AAN Meeting Affect Biogen, PTC Therapeutics, GW Pharma Or Isis Pharma?Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus – Analyst Blog(Zacks)In this week’s episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights.In the episode, Joe discusses Biogen Inc (NASDAQ: BIIB) new […]
The biotech segment has been growing well surpassing all expectations until Monday when shares slipped significantly. The NASDAQ Biotechnology Index ^NBI and NYSE ARCA BIOTECH INDEX ^BTK had gained 16.7% and 18.7%, respectively, til Apr 24 but both declined more than 4% on Monday after disappointing news from several biotech companies.Just when news of several mergers & acquisitions, product approvals […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
